- 23. Feb.
- 3 Min.
ODI Pharma AB: Publication of half-year report 2022/2023
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2022. The report is available...
ODI Pharma AB, based on it's European network, subsidiaries and affiliates, is a producer of pharmaceutical cannabis products with a focus on distribution to medicinal markets in Europe. The main focus of ODI Pharma is on the medicinal cannabis products that are sold to clients and patients through ODI Pharma's relationships to pharmacies via wholesale distributors.
ODI Pharma AB was founded and is lead by a team of professionals that benefits from it's excessive experience as doctors, researchers, investors and corporate managers.
ODI Pharma AB strives to improve the life of its patients and clients by providing state-of-the-art product, initiating and supporting research and promoting alternative ways of medication.
Today, medicinal cannabis is a catch-all term for anything from dried cannabis flowers, cannabis oils, capsules, tablets, oromucosal spray and so on. But common to all of these product types is that...
ODI Pharma's products are available only to medical patients through a prescription from a doctor. Research suggests that there are multiple applications for the product in standard and alternative medication...
Cannabis has evidently been used to treat severe ailments for as long as 8'000 years. The list below describes a short outline of the major events in history....
ODI's vision is to be a European pharmaceutical leader in the field of providing high quality cannabis products backed by science and innovation.